Local hospital testing new coronavirus treatment


ALBANY, N.Y. (NEWS10) — A drug called remdesivir has showed promise in Phase 3 of coronavirus treatment trials, and a local hospital is also working with it.

St. Peter’s Health Partners is working with drug maker Gilead on an expanded access trial study. In the study, they are providing the medication to nine critically ill patients. All nine have been on a ventilator and are roughly 10 to 11 days into the treatment.

“The treatment works by preventing the virus from replicating itself and infecting other cells in a person who is infected with coronavirus,” Dr. Philip Palmieri, Chief of Infectious Disease at St. Peter’s Hospital, said.

Dr. Palmieri said trials are important as there is still no treatment for COVID-19.

County-by-county Coronavirus Tracker
COVID-19 Resources
Reopening New York
More Coronavirus Coverage from News10


Copyright 2020 Nexstar Broadcasting, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Click Below to set up your cable box

Download our news app

App Store Link
Google Play Link

Coronavirus Outbreak

More Coronavirus Outbreak

Classroom Progress Report

More Classroom Progress Report